Reneo Pharmaceuticals
Income Statement
Last updated:
Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. over the previous period. Total operating expenses were $83,053,000.
Profit Margin
| 2019 | 0 | -12.43M | |
|---|---|---|---|
| 2020 | 0 | -19.46M | |
| 2021 | 0 | -39.77M | |
| 2022 | 0 | -50.06M | |
| 2023 | 0 | -77.38M |
RPHM Income Statement (2019 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|
Revenue | |||||
Revenue | 0 | 0 | 0 | 0 | 0 |
Cost of revenue | 525K | 529K | 50K | 37K | 34K |
Gross profit | -525K | -529K | -50K | -37K | -34K |
Operating exp. | |||||
Research and development | 56.61M | 37.70M | 28.16M | 15.94M | 13.09M |
Selling and marketing | 26.43M | 0 | 0 | 0 | 0 |
Total operating expenses | 83.05M | 53.84M | 39.81M | 19.55M | 15.47M |
Operating income | -83.05M | -53.84M | -39.81M | -19.55M | -15.47M |
Other income (expenses), net | 5.66M | 1.89M | 48K | 87K | 3.03M |
Income before tax | -77.38M | -51.95M | -39.77M | -19.46M | -12.43M |
Income tax expense | 650K | -1.89M | 0 | -169.29K | 0 |
Net income | -77.38M | -50.06M | -39.77M | -19.46M | -12.43M |
Earnings per share | |||||
Basic EPS | -25.23 | -2.04 | -2.19 | -0.8 | -1.6 |
Diluted EPS | -25.23 | -2.04 | -2.19 | -0.8 | -1.6 |
| Data source | Data source | Data source |